---
title: "Publications"
date: 2026-02-22
---

## Journal Articles

**Agrawal, R.\***, Albers, P.\*, Lima, J.F.\*, Huang, G., Mookerji, N., Pfanner, T., Hui, A., Mittal, R., Broomfield, S., Dean, L., St. Martin, B., Jacobsen, N.-E., Evans, H., Patel, Y., Yamaguchi, T.N., Livingstone, J.M., Haas, R., Wu, S., Pashminehazar, K., Hugh-White, R., Gonzalez, A., Gamallat, Y., Seyedi, S., Gao, Y., Hung, R., Abele, J., Dromparis, P., Michelakis, E., Sutendra, G., Wuest, F., Tu, W., Adam, B.A., Fung, C., Tamm, A., Bismar, T.A., Boutros, P.C., and Kinnaird, A. (2026). Molecular Hallmarks of PSMA PET Visibility in Prostate Cancer: A Secondary Analysis of The Phase 2 Next Generation Trial. *In submission.*

Bernard, M.J., Gallardo, A., Ruiz, A., Diaz, J.A., Nunley, N.M., Dove, R.N., Zhang, S., Lee, E., Heering, K.Y., Varuzhanyan, G., Bopardikar, S., Hashimoto, T., **Agrawal, R.**, Smith, C.M., Wilde, B.R., Matulionis, N., Richards, H.M., Lee, S.C.S., Sharifi, M.N., Lang, J.M., Zhao, S.G., Witte, O.N., Haffner, M.C., Shackelford, D.B., Boutros, P.C., Christofk, H.R., and Goldstein, A.S. (2026). OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance. *Mol Cancer Res.* [doi:10.1158/1541-7786.MCR-25-0913](https://doi.org/10.1158/1541-7786.MCR-25-0913).

Patel, Y., Zhu, C., Yamaguchi, T.N., Wang, N.K., Wiltsie, N., Zeltser, N., Gonzalez, A.E., Winata, H.K., Pan, Y., Mootor, M.F.E., Sanders, T., Fitz-Gibbon, S.T., Kandoth, C., Livingstone, J., Liu, L.Y., Carlin, B., Holmes, A., Oh, J., Sahrmann, J., Tao, S., Eng, S., Hugh-White, R., Pashminehazar, K., Park, A., Beshlikyan, A., Jordan, M., Wu, S., Tian, M., Arbet, J., Neilsen, B., Haas, R., Bugh, Y.Z., Kim, G., Salmingo, J., Zhang, W., Anand, A., Hwang, E., Neiman-Golden, A., Steinberg, P., Zhao, W., Anand, P., **Agrawal, R.**, Tsai, B.L., and Boutros, P.C. (2026). metapipeline-DNA: A Comprehensive Germline & Somatic Genomics Nextflow Pipeline. *Cell Reports Methods.* [doi:10.1101/2024.09.04.611267](https://doi.org/10.1101/2024.09.04.611267).

**Agrawal, R.**, Weiner, A.B., Livingstone, J., Pooli, A., Huang, R.R., Ye, H., Sisk, A., Elashoff, D.A., Boutros, P.C., Rettig, M.B., and Reiter, R.E. (2025). Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial. *Eur Urol Oncol.* PMID: 41207813. [doi:10.1016/j.euo.2025.10.013](https://doi.org/10.1016/j.euo.2025.10.013).

Arbet, J., Yamaguchi, T.N., Shiah, Y.-J., Hugh-White, R., Wiggins, A., Oh, J., Gebo, T., Foucal, A., Lesurf, R., Jung, C.-H., Dang, R.M.A., **Agrawal, R.**, Livingstone, J., Salcedo, A., Yao, C.Q., Espiritu, S.M.G., Houlahan, K.E., Yousif, F., Heisler, L.E., et al. (2025). The Landscape of Prostate Tumour Methylation. *bioRxiv.* [doi:10.1101/2025.02.07.637178](https://doi.org/10.1101/2025.02.07.637178).

**Agrawal, R.**, Al-Hiyari, S., Hugh-White, R., Hromas, R., Patel, Y., Williamson, E.A., Mootor, M.F.E., Gonzalez, A.E., Fu, J., Haas, R., Jordan, M., Wickes, B.L., Mohammed, G., Tian, M., Jobin, C., Yamaguchi, T.N., Herzon, S.B., Boutros, P.C., and Liss, M.A. (2025). Colibactin Exerts Androgen-Dependent and -Independent Effects on Prostate Cancer. *European Urology Oncology.*

Haas, R., Patel, Y., Liu, L.Y., Huang, R.R., Weiner, A., Yamaguchi, T.N., **Agrawal, R.**, Boutros, P.C., and Reiter, R.E. (2024). Divergent Evolution in Bilateral Prostate Cancer: a Case Study. *medRxiv.* [doi:10.1101/2024.08.22.24312320](https://doi.org/10.1101/2024.08.22.24312320).

Wang, N.K., Wiltsie, N., Winata, H.K., Fitz-Gibbon, S., Gonzalez, A.E., Zeltser, N., **Agrawal, R.**, Oh, J., Arbet, J., Patel, Y., et al. (2024). StableLift: Optimized Germline and Somatic Variant Detection Across Genome Builds. *bioRxiv.* [doi:10.1101/2024.10.31.621401](https://doi.org/10.1101/2024.10.31.621401).

Weiner, A.B., **Agrawal, R.**, Wang, N.K., Sonni, I., Li, E.V., Arbet, J., Zhang, J.J.H., Proudfoot, J.A., Hong, B.H., Davicioni, E., et al. (2024). Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer. *Eur Urol.* [doi:10.1016/j.eururo.2024.09.005](https://doi.org/10.1016/j.eururo.2024.09.005).

Weiner, A.B., **Agrawal, R.**, Valle, L.F., Sonni, I., Kishan, A.U., Rettig, M.B., Raman, S.S., Calais, J., Boutros, P.C., and Reiter, R.E. (2024). Impact of PSMA PET on Prostate Cancer Management. *Curr Treat Options Oncol.* [doi:10.1007/s11864-024-01181-9](https://doi.org/10.1007/s11864-024-01181-9).

Crowell, P.D., Giafaglione, J.M., Jones, A.E., Nunley, N.M., Hashimoto, T., Delcourt, A.M.L., Petcherski, A., **Agrawal, R.**, Bernard, M.J., Diaz, J.A., et al. (2023). MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. *Cell Reports* 42. [doi:10.1016/j.celrep.2023.113221](https://doi.org/10.1016/j.celrep.2023.113221).

Wang, D., **Agrawal, R.**, Zou, S., Haseeb, M.A., and Gupta, R. (2022). Anatomic location of colorectal cancer presents a new paradigm for its prognosis in African American patients. *PLoS ONE* 17, 1-14. [doi:10.1371/journal.pone.0271629](https://doi.org/10.1371/journal.pone.0271629).

Gupta, R., **Agrawal, R.**, Bukhari, Z., Jabbar, A., Wang, D., Diks, J., Alshal, M., Emechebe, D.Y., Brunicardi, F.C., Lazar, J.M., et al. (2021). Higher comorbidities and early death in hospitalized African-American patients with Covid-19. *BMC Infectious Diseases* 21, 78. [doi:10.1186/s12879-021-05782-9](https://doi.org/10.1186/s12879-021-05782-9).

Mendoza, R.P., Haidary, T., Gabutan, E., Zhou, Y.Y., Bukhari, Z., Connelly, C., Lee, W.-C., Lee, Y.-C., Wadgaonkar, R., **Agrawal, R.**, et al. (2021). Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer. *Sci Rep* 11, 14064. [doi:10.1038/s41598-021-93485-1](https://doi.org/10.1038/s41598-021-93485-1).

**Agrawal, R.**, and Prabakaran, S. (2020). Big data in digital healthcare: lessons learnt and recommendations for general practice. *Heredity* 124, 525-534. [doi:10.1038/s41437-020-0303-2](https://doi.org/10.1038/s41437-020-0303-2).

**Agrawal, R.**, Chen, M., Bukhari, Z., Ogunwobi, O.O., Haseeb, M.A., and Martello, L.A. (2020). EZH2 Downregulation Augments the Effect of Irradiation in Reducing Pancreatic Cancer Cell Proliferation in vitro. *Ann. Clin. Lab. Sci.* 50, 45-56.

Xia, R., Boroujeni, A.M., Shea, S., Pan, Y., **Agrawal, R.**, Yousefi, E., Fiel, M.I., Haseeb, M.A., and Gupta, R. (2019). Diagnosis of Liver Neoplasms by Computational and Statistical Image Analysis. *Gastroenterology Res* 12, 288-298. [doi:10.14740/gr1210](https://doi.org/10.14740/gr1210).

Haseeb, M.A., **Agrawal, R.**, and Fried, B. (2017). Reduced [14C]-methionine uptake and fecundity in Schistosoma mansoni females treated with recombinant tumor necrosis factor α in vitro. *Acta Parasitologica* 62, 164-170. [doi:10.1515/ap-2017-0019](https://doi.org/10.1515/ap-2017-0019).

---

## Conference Articles

Weiner, A.B., **Agrawal, R.**, Wang, N., Sonni, I., Li, E., Zhang, J.J., Davicioni, E., Valle, L.F., Rettig, M.B., Ross, A.E., et al. (2024). PD42-05 Correlating Prostate-Specific Membrane Antigen with Molecular Pathways in Treatment Naive Prostate Cancer. *Journal of Urology* 211, e894. [doi:10.1097/01.JU.0001008560.54103.65.05](https://doi.org/10.1097/01.JU.0001008560.54103.65.05).

Weiner, A.B., Wang, N., **Agrawal, R.**, Sonni, I., Valle, L., Kishan, A., Shen, J., Rettig, M., Calais, J., Boutros, P., et al. (2024). Molecular Correlates with PSMA Expression In Primary Prostate Cancer. *Urologic Oncology: Seminars and Original Investigations* 42, S85. [doi:10.1016/j.urolonc.2024.01.238](https://doi.org/10.1016/j.urolonc.2024.01.238).

Wang, D., Alawad, M., **Agrawal, R.**, Haseeb, M., and Gupta, R. (2019). KRAS Mutation, But Not Mismatch Repair Deficiency, Occurs with Increased Frequency in African American Patients with Colorectal Cancer and Predicts Poor Disease-Free Survival. *Modern Pathology* 32, 1-164.

Mendoza, R., Zhou, Y., **Agrawal, R.**, Gabutan, E., Haidary, T., Lee, W., Lee, Y., and Gupta, R. (2019). PD-L1, PD-1 Expression and DNA Mismatch Repair Genes in Cervical Squamous Cell Carcinoma, and Their Prognostic Significance. *Modern Pathology* 32, 1-140.

Gupta, R., **Agrawal, R.**, and Haseeb, M.A. (2013). Myeloid-Related Protein (MRP-18 and MRP-14) expressing cells in hepatic circumoval granulomata in murine Schistosomiasis. *Archives of Pathology and Laboratory Medicine* 137, 1514.

---

## Invited Presentations

**Agrawal, R.** "Genomic Markers of Aggression in Prostate Cancer Model Systems." Jonsson Comprehensive Cancer Center (JCCC) Symposium, Los Angeles, CA. May 2025.

**Agrawal, R.** "Dissecting Prostate Cancer Heterogeneity." Prostate Cancer SPORE Meeting, Los Angeles, CA. February 2025.

**Agrawal, R.** "The Role of the Microbiome in Prostate Cancer." Department of Human Genetics Works in Progress Series, UCLA, Los Angeles, CA. November 2024.

---

## Selected Posters

**Agrawal, R.**, Al-Hiyari, S., Patel, Y., Xu, X., Zhu, C., Her, P., Yamaguchi, T.N., Ci, X., Wang, N.K., Teng, M., Gonzalez, A.E., Ng, C., Holmes, A., Arbet, J., Winata, H., Mootor, M.F.E., Hugh-White, R., He, H.H., Liu, S.K., Boutros, P.C. Genomic Markers of Aggression in Prostate Cancer Model Systems. JCCC Symposium, May 2024.

**Agrawal, R.**, Al-Hiyari, S., et al. Genomic Markers of Aggression in Prostate Cancer Model Systems. RSGDREAM, November 2023 & QCBio, September 2023.

**Agrawal, R.**, Hemberg, M. Single Cell Transcriptomics of Crohn's Disease and Ulcerative Colitis Uncovers Differential Gene Expression Patterns and Cellular Outgroup. Summer Undergraduate Research Symposium, Columbia University, 2019.

**Agrawal, R.**, Higher Incidence of Genital Carcinosarcoma (MMMT) in African American Females in New York City. National Medical Association Annual Meeting, Philadelphia, PA, 2017.
